Opioids and protection against ischemia-reperfusion injury: from experimental data to potential clinical applications
- PMID: 22783707
Opioids and protection against ischemia-reperfusion injury: from experimental data to potential clinical applications
Abstract
Ischemic preconditioning, first demonstrated in animal myocardium, is an intrinsic and ubiquitous mechanism of marked protection against ischemia. Accumulating evidences have established that endogenous opioid peptides and their receptors play an important role in this adaptive phenomenon in the heart and other major organs. Of interest for therapeutic developments, opioid receptor agonists have been administered successfully to improve tolerance against experimental ischemia-reperfusion in various tissues. Recent human studies now raise the possibility to exploit this opioid-induced protection in clinical cardiac ischemia. These remarkable anti-ischemic properties of opioids and their emerging potential for organ protection in perioperative medicine will be reviewed at the light of pertinent results from basic and clinical researches.
Similar articles
-
[Remote ischemic preconditioning].Usp Fiziol Nauk. 2009 Oct-Dec;40(4):64-78. Usp Fiziol Nauk. 2009. PMID: 19886189 Russian.
-
Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics?Eur J Anaesthesiol. 2007 Sep;24(9):733-45. doi: 10.1017/S0265021507000531. Epub 2007 Jun 7. Eur J Anaesthesiol. 2007. PMID: 17555610 Review.
-
Remote ischemic preconditioning attenuates ischemia-reperfusion injury-induced reductions in vascular function through release of endogenous opioids.J Appl Physiol (1985). 2025 Feb 1;138(2):571-576. doi: 10.1152/japplphysiol.00913.2024. Epub 2025 Jan 17. J Appl Physiol (1985). 2025. PMID: 39819103
-
Opioid-induced preconditioning: recent advances and future perspectives.Vascul Pharmacol. 2005 Apr-May;42(5-6):211-8. doi: 10.1016/j.vph.2005.02.003. Epub 2005 Mar 17. Vascul Pharmacol. 2005. PMID: 15922254 Review.
-
The role of opioid receptor agonists in ischemic preconditioning.Eur J Pharmacol. 2013 Nov 15;720(1-3):401-8. doi: 10.1016/j.ejphar.2013.10.001. Epub 2013 Oct 8. Eur J Pharmacol. 2013. PMID: 24120367 Review.
Cited by
-
Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?Drug Des Devel Ther. 2017 Mar 8;11:677-683. doi: 10.2147/DDDT.S126701. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28331287 Free PMC article.
-
The effect of dexmedetomidine and remifentanil on the postoperative sore throat after thyroidectomy.Medicine (Baltimore). 2020 Jul 17;99(29):e21060. doi: 10.1097/MD.0000000000021060. Medicine (Baltimore). 2020. PMID: 32702848 Free PMC article.
-
[Effect of dexmedetomidine postconditioning on myocardial ischemia-reperfusion injury and inflammatory response in diabetic rats].Nan Fang Yi Ke Da Xue Xue Bao. 2017 Nov 20;37(11):1506-1511. doi: 10.3969/j.issn.1673-4254.2017.11.13. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 29180332 Free PMC article. Chinese.
-
Effect of dexmedetomidine on myocardial ischemia-reperfusion injury.Int J Clin Exp Med. 2015 Nov 15;8(11):21166-72. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26885050 Free PMC article.
-
The effects of tramadol on hepatic ischemia/reperfusion injury in rats.Indian J Pharmacol. 2016 May-Jun;48(3):275-80. doi: 10.4103/0253-7613.182882. Indian J Pharmacol. 2016. PMID: 27298497 Free PMC article.